{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:00:15Z","timestamp":1772190015685,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04150-0","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:25:11Z","timestamp":1769822711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Isoniazid-induced alopecia in isoniazid-monoresistant pulmonary tuberculosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Emine","family":"Af\u015fin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eeref","family":"\u00d6zkara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma Ceren","family":"G\u00f6kdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"issue":"2","key":"4150_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5530\/ijopp.14.2.16","volume":"14","author":"LP Babu","year":"2021","unstructured":"Babu LP, Babu JV, George S, Robin N, Jose J. Adverse drug reactions in drug-resistant tuberculosis management: a clinical approach. Indian J Pharm Pract. 2021;14(2):73. https:\/\/doi.org\/10.5530\/ijopp.14.2.16.","journal-title":"Indian J Pharm Pract"},{"key":"4150_CR2","doi-asserted-by":"publisher","unstructured":"Rabahi MF, Silva J\u00fanior JLRD, Ferreira ACG, Tannus-Silva DGS, Conde MB Tuberculosis treatment. J Bras Pneumol. 2017 Nov-Dec;43(6):472\u201386. https:\/\/doi.org\/10.1590\/S1806-37562016000000388.","DOI":"10.1590\/S1806-37562016000000388"},{"key":"4150_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"4150_CR4","unstructured":"Diagnosis T. and Treatment Guide, 2nd Edition. Ankara, T\u00fcrkiye. May 2019."},{"key":"4150_CR5","doi-asserted-by":"publisher","unstructured":"Lehloenya RJ, Dheda K. Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the Art and into the future. Expert Rev Anti Infect Ther. 2012;10(4):475\u201386. https:\/\/doi.org\/10.1586\/eri.12.13.","DOI":"10.1586\/eri.12.13"},{"key":"4150_CR6","doi-asserted-by":"crossref","unstructured":"Relvas M, Oliveira-Soares R. Drugs and alopecia. Portuguese J Dermatology Venereol. 2022;80(3):199\u2013205.","DOI":"10.24875\/PJDV.22000006"},{"key":"4150_CR7","doi-asserted-by":"publisher","unstructured":"Dixit R, Qureshi D, Mathur S. Alopecia caused by Isoniazid. J Pharmacol Pharmacother. 2014;5(2):155\u20137. https:\/\/doi.org\/10.4103\/0976-500X.130081.","DOI":"10.4103\/0976-500X.130081"},{"issue":"3","key":"4150_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2174\/157488606777934477","volume":"1","author":"BM Piraccini","year":"2006","unstructured":"Piraccini BM, Iorizzo M, Rech G, Tosti A. Drug-induced hair disorders. Curr Drug Saf. 2006;1(3):301\u20135. https:\/\/doi.org\/10.2174\/157488606777934477.","journal-title":"Curr Drug Saf"},{"key":"4150_CR9","doi-asserted-by":"publisher","unstructured":"Tosti A, Pazzaglia M. Drug reactions affecting hair: diagnosis. Dermatol Clin. 2007;25(2):223\u2009\u2013\u200931, vii. https:\/\/doi.org\/10.1016\/j.det.2007.01.005","DOI":"10.1016\/j.det.2007.01.005"},{"key":"4150_CR10","unstructured":"Hair Loss or Alopecia. Cancer.Net. 2020. Available from: https:\/\/www.cancer.net\/coping-with-cancer\/physical-emotional-and-social-effects-cancer\/managing-physical-side-effects\/hair-loss-or-alopecia"},{"key":"4150_CR11","unstructured":"World Health Organization. Active tuberculosis drug-safety monitoring and management (aDSM): framework for implementation. World Health Organization; 2015."},{"key":"4150_CR12","doi-asserted-by":"publisher","unstructured":"Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, Sterling TR, et al. ATS (American thoracic Society) hepatotoxicity of antituberculosis therapy Subcommittee. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174(8):935\u201352. https:\/\/doi.org\/10.1164\/rccm.200510-1666ST.","DOI":"10.1164\/rccm.200510-1666ST"},{"key":"4150_CR13","doi-asserted-by":"crossref","unstructured":"Sachdeva RA, Nagar S, Dawar S, Parashar D. Isoniazid-induced alopecia: A rare entity. Indian J Chest Dis Allied Sci. 2020;62(2):69\u201370.","DOI":"10.5005\/ijcdas-62-2-69"},{"key":"4150_CR14","doi-asserted-by":"crossref","unstructured":"Van SEJ. Drug induced alopecia. In Hair Research Springer, Berlin, Heidelberg. 1981;469\u2009\u2013\u200974.","DOI":"10.1007\/978-3-642-81650-5_78"},{"key":"4150_CR15","unstructured":"Petri WA Jr. Chemotherapy of tuberculosis, Mycobacterium avium complexdisease and leprosy. In: Brunton LL, Lazo JS, Parker KL, editors. Goodmanand gilman\u2019s the Pharmacological basis of therapeutics. New York: McGraw-Hill; 2011. pp. 1556\u20138."},{"key":"4150_CR16","unstructured":"Russom M, Berhe A, Hagos L. Second-line anti-tuberculosis drugs and risk of alopecia: a retrospective cohort study. Adv Pharmacoepidemiol Drug Saf. 2018;7:233."},{"key":"4150_CR17","doi-asserted-by":"publisher","unstructured":"Dixit R, George J, Sharma AK, Chhabra N, Jangir SK, Mishra V. Ethionamide-induced gynecomastia. J Pharmacol Pharmacother. 2012;3(2):196\u20139. https:\/\/doi.org\/10.4103\/0976-500X.95532.","DOI":"10.4103\/0976-500X.95532"},{"key":"4150_CR18","doi-asserted-by":"crossref","unstructured":"Garg T, Yadav P, Agarwal S, Mendiratta V. Drug-induced diffuse hair loss in females: an observational study. Astrocyte. 2014;1(2):80.","DOI":"10.4103\/2349-0977.137849"},{"key":"4150_CR19","doi-asserted-by":"publisher","unstructured":"FitzGerald JM, Turner MT, Dean S, Elwood RK. Alopecia side-effect of antituberculosis drugs. Lancet. 1996;347(8999):472. https:\/\/doi.org\/10.1016\/s0140-6736(96)90048-3.","DOI":"10.1016\/s0140-6736(96)90048-3"},{"key":"4150_CR20","doi-asserted-by":"publisher","unstructured":"Af\u015fin E, Bolu F, Kaymak \u015e\u00d6, \u00d6zsar\u0131 E, Konuk S. Retrospective evaluation of 5-year tuberculosis cases in Bolu, Turkey (before, during and after the COVID-19 pandemic). Respir Med. 2025;247:108287. https:\/\/doi.org\/10.1016\/j.rmed.2025.108287.","DOI":"10.1016\/j.rmed.2025.108287"},{"key":"4150_CR21","doi-asserted-by":"crossref","unstructured":"Tella E. Isoniazid\/rifampicin. Reactions.2015; 1540, 175\u2009\u2013\u200928.","DOI":"10.1007\/s40278-015-8023-8"},{"key":"4150_CR22","doi-asserted-by":"publisher","unstructured":"Zhang X, Feng Y, Li D, Han J, Shi D. Scalp infection caused by Mycobacterium abscessus manifested as patchy alopecia in an immunocompetent female. Infect Drug Resist. 2023;16:5413\u20139. https:\/\/doi.org\/10.2147\/IDR.S416974.","DOI":"10.2147\/IDR.S416974"},{"key":"4150_CR23","doi-asserted-by":"crossref","unstructured":"Ankad BS, Beergouder SL, Khageshan AP. Atypical presentation of lupus vulgaris: A case report. Global J Dermatology Venereol. 2013;1(1):4\u20136.","DOI":"10.12970\/2310-998X.2013.01.01.2"},{"issue":"2","key":"4150_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1590\/abd1806-4841.20142334","volume":"89","author":"JBD Santos","year":"2014","unstructured":"Santos JBD, Figueiredo AR, Ferraz CE, Oliveira MHD, Silva PGD, Medeiros VLSD. Cutaneous tuberculosis: epidemiologic, etiopathogenic and clinical aspects-part I. An Bras Dermatol. 2014;89(2):219\u201328.","journal-title":"An Bras Dermatol"},{"issue":"3","key":"4150_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4103\/mamcjms.mamcjms_14_22","volume":"8","author":"A Bhatia","year":"2022","unstructured":"Bhatia A, Verma P, Singh AK. Tubercular osteomyelitis as scalp swelling and alopecia areata. MAMC J Med Sci. 2022;8(3):269\u201371.","journal-title":"MAMC J Med Sci"},{"key":"4150_CR26","unstructured":"Ndiaye M, Hane AA, Dieng MT, Ndir M, Ba O, Cissokho S, et al. Syndrome de Sharp compliqu\u00e9 d\u2019une tuberculose pulmonaire: \u00e0propos d\u2019un Cas [Sharp syndrome complicating pulmonary tuberculosis: Apropos of a Case]. Dakar Med. 1999;44(2):236\u20139."}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04150-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04150-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04150-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:57:42Z","timestamp":1772186262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04150-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4150"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04150-0","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for ethical approval was waived from our institution ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients provided written informed consent to publication of this report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}